Kim M. J. Verdurmen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Kim M. J. Verdurmen has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
- Rik Vullings
Department of Electrical Engineering, Eindhoven University of Technology, Eindhoven, The Netherlands
6 shared publications S. Guid Oei
Department of Obstetrics and Gynaecology, Máxima Medical Centre, Veldhoven, The Netherlands; Department of Electrical Engineering, Eindhoven University of Technology, Eindhoven, The Netherlands
5 shared publicationsJudith O.E.H. van Laar
Department of Obstetrics and Gynaecology, Maxima Medical Centre, Veldhoven, the Netherlands
4 shared publicationsAlexandra D.J. Hulsenboom
Department of Obstetrics and Gynaecology, Maxima Medical Centre, Veldhoven, the Netherlands
2 shared publicationsCarlijn Lempersz
Department of Obstetrics and Gynaecology, Maxima Medical Centre, Veldhoven, the Netherlands
2 shared publicationsGuy J.J. Warmerdam
Department of Electrical Engineering, Eindhoven University of Technology, Eindhoven, The Netherlands
2 shared publications
Latest Publications
- 1 April 2018
- Published by Elsevier in Early Human Development
- Vol. 119, 8-14
The influence of betamethasone on fetal heart rate variability, obtained by non-invasive fetal electrocardiogram recordings
- 1 April 2018
- Published by Elsevier in Early Human Development
- Vol. 119, 8-14
The influence of betamethasone on fetal heart rate variability, obtained by non-invasive fetal electrocardiogram recordings
- Open Access
- 14 April 2017
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 12 (4) , e0175823
The electrical heart axis and ST events in fetal monitoring: A post-hoc analysis following a multicentre randomised controlled trial
Reducing perinatal morbidity and mortality is one of the major challenges in modern health care. Analysing the ST segment of the fetal electrocardiogram was thought to be the breakthrough in fetal monitoring during labour. However, its implementation in clinical practice yields many false alarms and ST monitoring is highly dependent on cardiotocogram assessment, limiting its value for the prediction of fetal distress during labour. This study aims to evaluate the relation between physiological variations in the orientation of the fetal electrical heart axis and the occurrence of ST events. A post-hoc analysis was performed following a multicentre randomised controlled trial, including 1097 patients from two participating centres. All women were monitored with ST analysis during labour. Cases of fetal metabolic acidosis, poor signal quality, missing blood gas analysis, and congenital heart disease were excluded. The orientation of the fetal electrical heart axis affects the height of the initial T/QRS baseline, and therefore the incidence of ST events. We grouped tracings with the same initial baseline T/QRS value. We depicted the number of ST events as a function of the initial baseline T/QRS value with a linear regression model. A significant increment of ST events was observed with increasing height of the initial T/QRS baseline, irrespective of the fetal condition; correlation coefficient 0.63, p<0.001. The most frequent T/QRS baseline is 0.12. The orientation of the fetal electrical heart axis and accordingly the height of the initial T/QRS baseline should be taken into account in fetal monitoring with ST analysis.
- 14 April 2017
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 12 (4) , e0175823
Open AccessThe electrical heart axis and ST events in fetal monitoring: A post-hoc analysis following a multicentre randomised controlled trial
Reducing perinatal morbidity and mortality is one of the major challenges in modern health care. Analysing the ST segment of the fetal electrocardiogram was thought to be the breakthrough in fetal monitoring during labour. However, its implementation in clinical practice yields many false alarms and ST monitoring is highly dependent on cardiotocogram assessment, limiting its value for the prediction of fetal distress during labour. This study aims to evaluate the relation between physiological variations in the orientation of the fetal electrical heart axis and the occurrence of ST events. A post-hoc analysis was performed following a multicentre randomised controlled trial, including 1097 patients from two participating centres. All women were monitored with ST analysis during labour. Cases of fetal metabolic acidosis, poor signal quality, missing blood gas analysis, and congenital heart disease were excluded. The orientation of the fetal electrical heart axis affects the height of the initial T/QRS baseline, and therefore the incidence of ST events. We grouped tracings with the same initial baseline T/QRS value. We depicted the number of ST events as a function of the initial baseline T/QRS value with a linear regression model. A significant increment of ST events was observed with increasing height of the initial T/QRS baseline, irrespective of the fetal condition; correlation coefficient 0.63, p<0.001. The most frequent T/QRS baseline is 0.12. The orientation of the fetal electrical heart axis and accordingly the height of the initial T/QRS baseline should be taken into account in fetal monitoring with ST analysis.
- 1 December 2016
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology
- Vol. 207, 243-246
Orientation of the electrical heart axis in mid-term pregnancy
- 1 December 2016
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology
- Vol. 207, 243-246
Orientation of the electrical heart axis in mid-term pregnancy
- 8 November 2016
- Published by Taylor & Francis in The Journal of Maternal-Fetal & Neonatal Medicine
- Vol. 30 (20) , 2387-2394
Effect of tocolytic drugs on fetal heart rate variability: a systematic review
Introduction: Tocolytics may cause changes in fetal heart rate (HR) pattern, while fetal heart rate variability (HRV) is an important marker of fetal well-being. We aim to systematically review the literature on how tocolytic drugs affect fetal HRV. Materials and methods: We searched CENTRAL, PubMed and EMBASE up to June 2016. Studies published in English, using computerized or visual analysis to describe the effect of tocolytics on HRV in human fetuses were included. Studies describing tocolytics during labor, external cephalic version, pre-eclampsia and infection were excluded. Eventually, we included six studies, describing 169 pregnant women. Results: Nifedipine, atosiban and indomethacin administration show no clinically important effect on fetal HRV. Following administration of magnesium sulfate decreased variability and cases of bradycardia are described. Fenoterol administration results in a slight increase in fetal HR with no changes in variability. After ritodrine administration increased fetal HR and decreased variability is seen. The effect of co-administration of corticosteroids should be taken into account. Conclusion: In order to prevent iatrogenic preterm labor, the effects of tocolytic drugs on fetal HRV should be taken into account when monitoring these fetuses.
- 8 November 2016
- Published by Taylor & Francis in The Journal of Maternal-Fetal & Neonatal Medicine
- Vol. 30 (20) , 2387-2394
Effect of tocolytic drugs on fetal heart rate variability: a systematic review
Introduction: Tocolytics may cause changes in fetal heart rate (HR) pattern, while fetal heart rate variability (HRV) is an important marker of fetal well-being. We aim to systematically review the literature on how tocolytic drugs affect fetal HRV. Materials and methods: We searched CENTRAL, PubMed and EMBASE up to June 2016. Studies published in English, using computerized or visual analysis to describe the effect of tocolytics on HRV in human fetuses were included. Studies describing tocolytics during labor, external cephalic version, pre-eclampsia and infection were excluded. Eventually, we included six studies, describing 169 pregnant women. Results: Nifedipine, atosiban and indomethacin administration show no clinically important effect on fetal HRV. Following administration of magnesium sulfate decreased variability and cases of bradycardia are described. Fenoterol administration results in a slight increase in fetal HR with no changes in variability. After ritodrine administration increased fetal HR and decreased variability is seen. The effect of co-administration of corticosteroids should be taken into account. Conclusion: In order to prevent iatrogenic preterm labor, the effects of tocolytic drugs on fetal HRV should be taken into account when monitoring these fetuses.
- 1 November 2016
- Published by Wiley in International Journal of Gynecology & Obstetrics
- Vol. 135 (2) , 129-134
A systematic review of prenatal screening for congenital heart disease by fetal electrocardiography
Background: Congenital heart disease (CHD) is the most common severe congenital anomaly worldwide. Diagnosis early in pregnancy is important, but the detection rate by two‐dimensional ultrasonography is only 65%–81%. Objectives: To evaluate existing data on CHD and noninvasive abdominal fetal electrocardiography (ECG). Search strategy: A systematic review was performed through a search of the Cochrane Library, PubMed, and Embase for studies published up to April 2016 using the terms “congenital heart disease,” “fetal electrocardiogram,” and other similar keywords. Selection criteria: Primary articles that described changes in fetal ECG among fetuses with CHD published in English were included. Data collection and analysis: Outcomes of interest were changes in fetal ECG parameters observed for fetuses with congenital heart disease. Findings were reported descriptively. Main results: Only five studies described changes observed in the fetal electrocardiogram for fetuses with CHD, including heart rate, heart rate variability, and PR, QRS, and QT intervals. Fetal ECG reflects the intimate relationship between the cardiac nerve conduction system and the structural morphology of the heart. It seems particularly helpful in detecting the electrophysiological effects of cardiac anatomic defects (e.g. hypotrophy, hypertrophy, and conduction interruption). Conclusions: Fetal ECG might be a promising clinical tool to complement ultrasonography in the screening program for CHD.
- 1 November 2016
- Published by Wiley in International Journal of Gynecology & Obstetrics
- Vol. 135 (2) , 129-134
A systematic review of prenatal screening for congenital heart disease by fetal electrocardiography
Background: Congenital heart disease (CHD) is the most common severe congenital anomaly worldwide. Diagnosis early in pregnancy is important, but the detection rate by two‐dimensional ultrasonography is only 65%–81%. Objectives: To evaluate existing data on CHD and noninvasive abdominal fetal electrocardiography (ECG). Search strategy: A systematic review was performed through a search of the Cochrane Library, PubMed, and Embase for studies published up to April 2016 using the terms “congenital heart disease,” “fetal electrocardiogram,” and other similar keywords. Selection criteria: Primary articles that described changes in fetal ECG among fetuses with CHD published in English were included. Data collection and analysis: Outcomes of interest were changes in fetal ECG parameters observed for fetuses with congenital heart disease. Findings were reported descriptively. Main results: Only five studies described changes observed in the fetal electrocardiogram for fetuses with CHD, including heart rate, heart rate variability, and PR, QRS, and QT intervals. Fetal ECG reflects the intimate relationship between the cardiac nerve conduction system and the structural morphology of the heart. It seems particularly helpful in detecting the electrophysiological effects of cardiac anatomic defects (e.g. hypotrophy, hypertrophy, and conduction interruption). Conclusions: Fetal ECG might be a promising clinical tool to complement ultrasonography in the screening program for CHD.
- Open Access
- 17 August 2016
- Published by Springer Nature in BMC Pregnancy and Childbirth
- Vol. 16 (1) , 1-7
Normal ranges for fetal electrocardiogram values for the healthy fetus of 18–24 weeks of gestation: a prospective cohort study
The fetal anomaly ultrasound only detects 65 to 81 % of the patients with congenital heart disease, making it the most common structural fetal anomaly of which a significant part is missed during prenatal life. Therefore, we need a reliable non-invasive diagnostic method which improves the predictive value for congenital heart diseases early in pregnancy. Fetal electrocardiography could be this desired diagnostic method. There are multiple technical challenges to overcome in the conduction of the fetal electrocardiogram. In addition, interpretation is difficult due to the organisation of the fetal circulation in utero. We want to establish the normal ranges and values of the fetal electrocardiogram parameters in healthy fetuses of 18 to 24 weeks of gestation. Women with an uneventful singleton pregnancy between 18 and 24 weeks of gestation are asked to participate in this prospective cohort study. A certified and experienced sonographist performs the fetal anomaly scan. Subsequently, a fetal electrocardiogram recording is performed using dedicated signal processing methods. Measurements are performed at two institutes. We will include 300 participants to determine the normal values and 95 % confidence intervals of the fetal electrocardiogram parameters in a healthy fetus. We will evaluate the fetal heart rate, segment intervals, normalised amplitude and the fetal heart axis. Three months postpartum, we will evaluate if a newborn is healthy through a questionnaire. Fetal electrocardiography could be a promising tool in the screening program for congenital heart diseases. The electrocardiogram is a depiction of the intimate relationship between the cardiac nerve conduction pathways and the structural morphology of the fetal heart, and therefore particularly suitable for the detection of secondary effects due to a congenital heart disease (hypotrophy, hypertrophy and conduction interruption).
- 17 August 2016
- Published by Springer Nature in BMC Pregnancy and Childbirth
- Vol. 16 (1) , 1-7
Open AccessNormal ranges for fetal electrocardiogram values for the healthy fetus of 18–24 weeks of gestation: a prospective cohort study
The fetal anomaly ultrasound only detects 65 to 81 % of the patients with congenital heart disease, making it the most common structural fetal anomaly of which a significant part is missed during prenatal life. Therefore, we need a reliable non-invasive diagnostic method which improves the predictive value for congenital heart diseases early in pregnancy. Fetal electrocardiography could be this desired diagnostic method. There are multiple technical challenges to overcome in the conduction of the fetal electrocardiogram. In addition, interpretation is difficult due to the organisation of the fetal circulation in utero. We want to establish the normal ranges and values of the fetal electrocardiogram parameters in healthy fetuses of 18 to 24 weeks of gestation. Women with an uneventful singleton pregnancy between 18 and 24 weeks of gestation are asked to participate in this prospective cohort study. A certified and experienced sonographist performs the fetal anomaly scan. Subsequently, a fetal electrocardiogram recording is performed using dedicated signal processing methods. Measurements are performed at two institutes. We will include 300 participants to determine the normal values and 95 % confidence intervals of the fetal electrocardiogram parameters in a healthy fetus. We will evaluate the fetal heart rate, segment intervals, normalised amplitude and the fetal heart axis. Three months postpartum, we will evaluate if a newborn is healthy through a questionnaire. Fetal electrocardiography could be a promising tool in the screening program for congenital heart diseases. The electrocardiogram is a depiction of the intimate relationship between the cardiac nerve conduction pathways and the structural morphology of the fetal heart, and therefore particularly suitable for the detection of secondary effects due to a congenital heart disease (hypotrophy, hypertrophy and conduction interruption).
- 3 December 2013
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 93 (1) , 93-101
Fetal heart rate variability during pregnancy, obtained from non‐invasive electrocardiogram recordings
Objective: Non‐invasive spectral analysis of fetal heart rate variability is a promising new field of fetal monitoring. To validate this method properly, we studied the relationship between gestational age and the influence of fetal rest–activity state on spectral estimates of fetal heart rate variability.Design: Prospective longitudinal study.Setting: Tertiary care teaching hospital.Population: Forty healthy women with an uneventful singleton pregnancy.Methods: Non‐invasive fetal electrocardiogram measurements via the maternal abdomen were performed at regular intervals between 14 and 40 weeks of gestation and processed to detect beat‐to‐beat fetal heart rate. Simultaneous ultrasound recordings were performed to assess fetal rest–activity state.Main outcome measures: Absolute and normalized power of fetal heart rate variability in the low (0.04–0.15 Hz) and high (0.4–1.5 Hz) frequency band were obtained, using Fourier Transform.Results: 14% of all measurements and 3% of the total amount of abdominal data (330 segments) was usable for spectral analysis. During 21–30 weeks of gestation, a significant increase in absolute low and high frequency power was observed. During the active state near term, absolute and normalized low frequency power were significantly higher and normalized high frequency power was significantly lower compared with the quiet state.Conclusions: The observed increase in absolute spectral estimates in preterm fetuses was probably due to increased sympathetic and parasympathetic modulation and might be a sign of autonomic development. Further improvements in signal processing are needed before this new method of fetal monitoring can be introduced in clinical practice.
- 3 December 2013
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 93 (1) , 93-101
Fetal heart rate variability during pregnancy, obtained from non‐invasive electrocardiogram recordings
Objective: Non‐invasive spectral analysis of fetal heart rate variability is a promising new field of fetal monitoring. To validate this method properly, we studied the relationship between gestational age and the influence of fetal rest–activity state on spectral estimates of fetal heart rate variability.Design: Prospective longitudinal study.Setting: Tertiary care teaching hospital.Population: Forty healthy women with an uneventful singleton pregnancy.Methods: Non‐invasive fetal electrocardiogram measurements via the maternal abdomen were performed at regular intervals between 14 and 40 weeks of gestation and processed to detect beat‐to‐beat fetal heart rate. Simultaneous ultrasound recordings were performed to assess fetal rest–activity state.Main outcome measures: Absolute and normalized power of fetal heart rate variability in the low (0.04–0.15 Hz) and high (0.4–1.5 Hz) frequency band were obtained, using Fourier Transform.Results: 14% of all measurements and 3% of the total amount of abdominal data (330 segments) was usable for spectral analysis. During 21–30 weeks of gestation, a significant increase in absolute low and high frequency power was observed. During the active state near term, absolute and normalized low frequency power were significantly higher and normalized high frequency power was significantly lower compared with the quiet state.Conclusions: The observed increase in absolute spectral estimates in preterm fetuses was probably due to increased sympathetic and parasympathetic modulation and might be a sign of autonomic development. Further improvements in signal processing are needed before this new method of fetal monitoring can be introduced in clinical practice.